ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EGRX

NEW YORK, Jan. 26, 2024 /PRNewswire/ --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8, 2023 and November 28, 2023, both dates inclusive (the "Class Period"), of the important February 9, 2024 lead plaintiff deadline.

Read more at prnewswire.com